Prime Capital Investment Advisors’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$318K Sell
1,512
-158
-9% -$33.9K ﹤0.01% 841
2026
Q1
$369K Buy
1,670
+27
+2% +$6.61K ﹤0.01% 763
2025
Q4
$416K Buy
1,643
+21
+1% +$5.27K 0.01% 703
2025
Q3
$401K Buy
1,622
+13
+0.8% +$3.11K 0.01% 705
2025
Q2
$386K Sell
1,609
-59
-4% -$13.7K 0.01% 693
2025
Q1
$378K Buy
1,668
+61
+4% +$13.4K ﹤0.01% 759
2024
Q4
$330K Sell
1,607
-352
-18% -$77.2K ﹤0.01% 699
2024
Q3
$475K Sell
1,959
-682
-26% -$159K 0.01% 606
2024
Q2
$580K Sell
2,641
-3,425
-56% -$744K 0.01% 544
2024
Q1
$1.36M Sell
6,066
-6,397
-51% -$1.44M 0.02% 414
2023
Q4
$2.74M Buy
+12,463
New +$2.64M 0.04% 285
2020
Q2
Sell
-136
Closed -$19K 520
2020
Q1
$19K Hold
136
﹤0.01% 364
2019
Q4
$21K Hold
136
﹤0.01% 404
2019
Q3
$20K Buy
+136
New +$20.3K ﹤0.01% 420

Other funds holding STE

Prime Capital Investment Advisors's STE Position: Q2 2026 in Review

Prime Capital Investment Advisors reduced its Steris (STE) stake by 9.5% in Q2 2026, selling an estimated $33.9K and leaving 1,512 shares worth $318K. The position accounts for ﹤0.01% of the portfolio, ranked #841.

Prime Capital Investment Advisors first reported a position in STE in Q3 2019 and has held it in 14 quarters since. The position peaked at $2.74M in Q4 2023. 575 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Prime Capital Investment Advisors held 1,512 shares of Steris worth $318K as of Q2 2026.
  • Prime Capital Investment Advisors sold 158 Steris shares in Q2 2026, an estimated $33.9K.
  • Steris made up ﹤0.01% of Prime Capital Investment Advisors's portfolio in Q2 2026, its #841 holding.
  • Prime Capital Investment Advisors first reported a position in Steris in Q3 2019 and has held it in 14 quarters since.
  • Prime Capital Investment Advisors's Steris position peaked at $2.74M in Q4 2023.
  • 575 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Prime Capital Investment Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.